Current Pharmaceutical Design

9.8k papers and 299.2k indexed citations

About

The 9.8k papers published in Current Pharmaceutical Design in the last decades have received a total of 299.2k indexed citations. Papers published in Current Pharmaceutical Design usually cover Molecular Biology (3.2k papers), Oncology (906 papers) and Pharmacology (789 papers) specifically the topics of Computational Drug Discovery Methods (446 papers), Nanoparticle-Based Drug Delivery (339 papers) and RNA Interference and Gene Delivery (261 papers). The most active scholars publishing in Current Pharmaceutical Design are Claudiu T. Supuran, Sho‐ichi Yamagishi, K. Hüsnü Can Başer, Amirhossein Sahebkar, Michael J. Rogers, William A. Banks, James E. Klaunig, David J. Begley, Hannu T. Korhonen and Anne Pihlanto.

In The Last Decade

Current Pharmaceutical Design

9.2k papers receiving 282.4k citations

Peers

Current Pharmaceutical Design
Comparison fields: 5 of 236
  • Molecular Biology 114.3k
  • Physiology 29.8k
  • Oncology 27.4k
  • Pharmacology 25.1k
  • Immunology 23.6k
Replace Pharmacological Research with:
Pharmacological Research Italy
Current Medicinal Chemistry Italy
Pharmacology & Therapeutics United States
Biochemical Society Transactions United Kingdom
Toxicology and Applied Pharmacology United States
The Journal of Biochemistry Japan
Molecular and Cellular Biochemistry United States
Biochimica et Biophysica Acta (BBA) - General Subjects United States
Drugs United States
Frontiers in Pharmacology China
Pharmacological Research Italy View profile →
Citations per field, relative to Current Pharmaceutical Design
Current Pharmaceutical Design · 1×
Citations per year, relative to Current Pharmaceutical Design
Current Pharmaceutical Design · 1×

Countries where authors publish in Current Pharmaceutical Design

Since Specialization
Citations

This map shows the geographic impact of research published in Current Pharmaceutical Design. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Pharmaceutical Design with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Pharmaceutical Design more than expected).

Fields of papers published in Current Pharmaceutical Design

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Pharmaceutical Design. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Pharmaceutical Design.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2026